- Bloomberg•8 months ago
Genomma Lab Internacional SAB, the Mexican seller of remedies for acne and baldness, fell the most in eight months after a news report that a drug distributor in which the company sold a majority stake ...
- Bloomberg•last year
Genomma Lab Internacional SAB, the Mexican drug company whose shares are trading near a six-year low, is scrapping about 20 lesser-known brands as part of an effort to streamline operations and grow abroad ...
- Bloomberg•2 years ago
Chief Executive Officer Rodrigo Herrera, whose family holds about 30 percent of the shares, said in an interview that Genomma plans to license out at least 15 brands and use the extra cash to pay down debt and buy back shares. “The best investment that we can make is in our own company, and not do any acquisitions right now,” Herrera said in an interview Friday. The CEO is changing tack after his company’s stock tumbled 41 percent this year, the worst performance on Mexico’s benchmark IPC gauge.
LABB.MX : Summary for GENOMMA LAB INTERNACIONAL, S.A. - Yahoo Finance
Genomma Lab Internacional, S.A.B. de C.V. (LABB.MX)
Mexico - Mexico Delayed Price. Currency in MXN
Add to watchlist
|Bid||24.20 x 50000|
|Ask||24.28 x 194200|
|Day's Range||23.56 - 24.35|
|52 Week Range||11.40 - 25.47|
|PE Ratio (TTM)||-43.13|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|